�ݺ�ߣshows by User: simbupharma12

�ݺ�ߣshows by User: simbupharma12 / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: simbupharma12 / Sat, 29 May 2021 16:33:17 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: simbupharma12 Invitro drug product performance /slideshow/invitro-drug-product-performance/248746216 invitrodrugproductperformance-converted-210529163318
Dissolution profile comparisons, Drug product stability, Considerations in the design of a Drug product ]]>
Dissolution profile comparisons, Drug product stability, Considerations in the design of a Drug product ]]> Sat, 29 May 2021 16:33:17 GMT /slideshow/invitro-drug-product-performance/248746216 simbupharma12@slideshare.net(simbupharma12) Invitro drug product performance simbupharma12 Dissolution profile comparisons, Drug product stability, Considerations in the design of a Drug product <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/invitrodrugproductperformance-converted-210529163318-thumbnail.jpg?width=120&height=120&fit=bounds" /> Dissolution profile comparisons, Drug product stability, Considerations in the design of a Drug product

Invitro drug product performance from silambarasan I

]]> 2614 0 https://cdn.slidesharecdn.com/ss_thumbnails/invitrodrugproductperformance-converted-210529163318-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Herbal ingredients in Oral care /slideshow/herbal-ingredients-in-oral-care-248746158/248746158 herbalingredientsinoralcaresimbu280320-210529162848
Herbal Cosmetics]]>
Herbal Cosmetics]]> Sat, 29 May 2021 16:28:47 GMT /slideshow/herbal-ingredients-in-oral-care-248746158/248746158 simbupharma12@slideshare.net(simbupharma12) Herbal ingredients in Oral care simbupharma12 Herbal Cosmetics <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/herbalingredientsinoralcaresimbu280320-210529162848-thumbnail.jpg?width=120&height=120&fit=bounds" /> Herbal Cosmetics

Herbal ingredients in Oral care from silambarasan I

]]> 1249 0 https://cdn.slidesharecdn.com/ss_thumbnails/herbalingredientsinoralcaresimbu280320-210529162848-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Perfumes /slideshow/perfumes-248746146/248746146 perfumesimbu040420-210529162733
Classification of perfumes. Perfume ingredients listed as allergens in EU regulation.]]>
Classification of perfumes. Perfume ingredients listed as allergens in EU regulation.]]> Sat, 29 May 2021 16:27:33 GMT /slideshow/perfumes-248746146/248746146 simbupharma12@slideshare.net(simbupharma12) Perfumes simbupharma12 Classification of perfumes. Perfume ingredients listed as allergens in EU regulation. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/perfumesimbu040420-210529162733-thumbnail.jpg?width=120&height=120&fit=bounds" /> Classification of perfumes. Perfume ingredients listed as allergens in EU regulation.

Perfumes from silambarasan I

]]> 2602 0 https://cdn.slidesharecdn.com/ss_thumbnails/perfumesimbu040420-210529162733-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Cosmetics - Regulatory Aspects /slideshow/cosmetics-regulatory-aspects/248746112 cosmeticsregulatorysimbu310320-210529162458
Definition of cosmetic products as per Indian regulation. Indian regulatory requirements for labeling of cosmetics .Regulatory provisions relating to import of cosmetics ,Misbranded and spurious cosmetics. Regulatory provisions relating to manufacture of cosmetics – Conditions for obtaining license, prohibition of manufacture and sale of certain cosmetics, loan license, offences and penalties.]]>
Definition of cosmetic products as per Indian regulation. Indian regulatory requirements for labeling of cosmetics .Regulatory provisions relating to import of cosmetics ,Misbranded and spurious cosmetics. Regulatory provisions relating to manufacture of cosmetics – Conditions for obtaining license, prohibition of manufacture and sale of certain cosmetics, loan license, offences and penalties.]]> Sat, 29 May 2021 16:24:58 GMT /slideshow/cosmetics-regulatory-aspects/248746112 simbupharma12@slideshare.net(simbupharma12) Cosmetics - Regulatory Aspects simbupharma12 Definition of cosmetic products as per Indian regulation. Indian regulatory requirements for labeling of cosmetics .Regulatory provisions relating to import of cosmetics ,Misbranded and spurious cosmetics. Regulatory provisions relating to manufacture of cosmetics – Conditions for obtaining license, prohibition of manufacture and sale of certain cosmetics, loan license, offences and penalties. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cosmeticsregulatorysimbu310320-210529162458-thumbnail.jpg?width=120&height=120&fit=bounds" /> Definition of cosmetic products as per Indian regulation. Indian regulatory requirements for labeling of cosmetics .Regulatory provisions relating to import of cosmetics ,Misbranded and spurious cosmetics. Regulatory provisions relating to manufacture of cosmetics – Conditions for obtaining license, prohibition of manufacture and sale of certain cosmetics, loan license, offences and penalties.

Cosmetics - Regulatory Aspects from silambarasan I

]]> 2676 0 https://cdn.slidesharecdn.com/ss_thumbnails/cosmeticsregulatorysimbu310320-210529162458-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Quality by Design in Pharmaceutical Development /slideshow/quality-by-design-in-pharmaceutical-development-248746086/248746086 qbdsimbu120520-210529162259
Introduction, ICH Q8 guideline, Regulatory and industry views on QbD, Scientifically based QbD - examples of application]]>
Introduction, ICH Q8 guideline, Regulatory and industry views on QbD, Scientifically based QbD - examples of application]]> Sat, 29 May 2021 16:22:58 GMT /slideshow/quality-by-design-in-pharmaceutical-development-248746086/248746086 simbupharma12@slideshare.net(simbupharma12) Quality by Design in Pharmaceutical Development simbupharma12 Introduction, ICH Q8 guideline, Regulatory and industry views on QbD, Scientifically based QbD - examples of application <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/qbdsimbu120520-210529162259-thumbnail.jpg?width=120&height=120&fit=bounds" /> Introduction, ICH Q8 guideline, Regulatory and industry views on QbD, Scientifically based QbD - examples of application

Quality by Design in Pharmaceutical Development from silambarasan I

]]> 1162 0 https://cdn.slidesharecdn.com/ss_thumbnails/qbdsimbu120520-210529162259-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 History of computers in Pharmaceutical research & Development /slideshow/history-of-computers-in-pharmaceutical-research-development-248746061/248746061 historyofcomutersinpharmaceuticalresearchdevelopment-210529162055
Computers in Pharmaceutical Research and Development]]>
Computers in Pharmaceutical Research and Development]]> Sat, 29 May 2021 16:20:54 GMT /slideshow/history-of-computers-in-pharmaceutical-research-development-248746061/248746061 simbupharma12@slideshare.net(simbupharma12) History of computers in Pharmaceutical research & Development simbupharma12 Computers in Pharmaceutical Research and Development <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/historyofcomutersinpharmaceuticalresearchdevelopment-210529162055-thumbnail.jpg?width=120&height=120&fit=bounds" /> Computers in Pharmaceutical Research and Development

History of computers in Pharmaceutical research & Development from silambarasan I

]]> 808 0 https://cdn.slidesharecdn.com/ss_thumbnails/historyofcomutersinpharmaceuticalresearchdevelopment-210529162055-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Drug Absorption from GI Tract /simbupharma12/drug-absorption-from-gi-tract drugabsorptionfromgitractsimbu300420-210529161625
Gastrointestinal tract, Mechanism of drug absorption, Factors affecting drug absorption, pH–partition theory of drug absorption. Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: Role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate Intracellular pH Environment, Tight Junction Complex.]]>
Gastrointestinal tract, Mechanism of drug absorption, Factors affecting drug absorption, pH–partition theory of drug absorption. Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: Role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate Intracellular pH Environment, Tight Junction Complex.]]> Sat, 29 May 2021 16:16:25 GMT /simbupharma12/drug-absorption-from-gi-tract simbupharma12@slideshare.net(simbupharma12) Drug Absorption from GI Tract simbupharma12 Gastrointestinal tract, Mechanism of drug absorption, Factors affecting drug absorption, pH–partition theory of drug absorption. Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: Role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate Intracellular pH Environment, Tight Junction Complex. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/drugabsorptionfromgitractsimbu300420-210529161625-thumbnail.jpg?width=120&height=120&fit=bounds" /> Gastrointestinal tract, Mechanism of drug absorption, Factors affecting drug absorption, pH–partition theory of drug absorption. Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: Role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate Intracellular pH Environment, Tight Junction Complex.

Drug Absorption from GI Tract from silambarasan I

]]> 6937 0 https://cdn.slidesharecdn.com/ss_thumbnails/drugabsorptionfromgitractsimbu300420-210529161625-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Pulmonary Drug Delivery System /simbupharma12/pulmonary-drug-delivery-system-248745959 pddssimbu080520-210529161211
Pulmonary Drug Delivery System, Aerosols, Propellant's, Containers Types, Preparation and Evaluation]]>
Pulmonary Drug Delivery System, Aerosols, Propellant's, Containers Types, Preparation and Evaluation]]> Sat, 29 May 2021 16:12:10 GMT /simbupharma12/pulmonary-drug-delivery-system-248745959 simbupharma12@slideshare.net(simbupharma12) Pulmonary Drug Delivery System simbupharma12 Pulmonary Drug Delivery System, Aerosols, Propellant's, Containers Types, Preparation and Evaluation <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pddssimbu080520-210529161211-thumbnail.jpg?width=120&height=120&fit=bounds" /> Pulmonary Drug Delivery System, Aerosols, Propellant's, Containers Types, Preparation and Evaluation

Pulmonary Drug Delivery System from silambarasan I

]]> 2044 0 https://cdn.slidesharecdn.com/ss_thumbnails/pddssimbu080520-210529161211-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Pharmaceutical Liposomes /slideshow/pharmaceutical-liposomes/248745861 liposomessimbu250420-converted-210529160546
Types, Preparation and Evaluation of Liposomes]]>
Types, Preparation and Evaluation of Liposomes]]> Sat, 29 May 2021 16:05:44 GMT /slideshow/pharmaceutical-liposomes/248745861 simbupharma12@slideshare.net(simbupharma12) Pharmaceutical Liposomes simbupharma12 Types, Preparation and Evaluation of Liposomes <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/liposomessimbu250420-converted-210529160546-thumbnail.jpg?width=120&height=120&fit=bounds" /> Types, Preparation and Evaluation of Liposomes

Pharmaceutical Liposomes from silambarasan I

]]> 367 0 https://cdn.slidesharecdn.com/ss_thumbnails/liposomessimbu250420-converted-210529160546-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Pharmaceutical Nanoparticles /slideshow/pharmaceutical-nanoparticles/248745811 nanoparticlessimbu200420-210529160302
Types, Preparation and Evaluation of Nanoparticles]]>
Types, Preparation and Evaluation of Nanoparticles]]> Sat, 29 May 2021 16:03:02 GMT /slideshow/pharmaceutical-nanoparticles/248745811 simbupharma12@slideshare.net(simbupharma12) Pharmaceutical Nanoparticles simbupharma12 Types, Preparation and Evaluation of Nanoparticles <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nanoparticlessimbu200420-210529160302-thumbnail.jpg?width=120&height=120&fit=bounds" /> Types, Preparation and Evaluation of Nanoparticles

Pharmaceutical Nanoparticles from silambarasan I

]]> 942 0 https://cdn.slidesharecdn.com/ss_thumbnails/nanoparticlessimbu200420-210529160302-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 X ray Crystallography /slideshow/x-ray-crystallography-248745715/248745715 xraysimbu291019-210529155835
Production of X rays, Different X ray diffraction methods, Bragg‘s law, Rotating crystal technique, X ray powder technique, Types of crystals and applications of X-ray Diffraction]]>
Production of X rays, Different X ray diffraction methods, Bragg‘s law, Rotating crystal technique, X ray powder technique, Types of crystals and applications of X-ray Diffraction]]> Sat, 29 May 2021 15:58:35 GMT /slideshow/x-ray-crystallography-248745715/248745715 simbupharma12@slideshare.net(simbupharma12) X ray Crystallography simbupharma12 Production of X rays, Different X ray diffraction methods, Bragg‘s law, Rotating crystal technique, X ray powder technique, Types of crystals and applications of X-ray Diffraction <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/xraysimbu291019-210529155835-thumbnail.jpg?width=120&height=120&fit=bounds" /> Production of X rays, Different X ray diffraction methods, Bragg‘s law, Rotating crystal technique, X ray powder technique, Types of crystals and applications of X-ray Diffraction

X ray Crystallography from silambarasan I

]]> 1702 0 https://cdn.slidesharecdn.com/ss_thumbnails/xraysimbu291019-210529155835-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Documentation In Pharmaceutical Industry /slideshow/documentation-in-pharmaceutical-industry-248745573/248745573 ra031219-210529155143
Master formula record, DMF (Drug Master File), Distribution records. Generic drugs product development Introduction , Hatch-Waxman act and Amendments, CFR (CODE OF FEDERAL REGULATION) ,Drug product performance, In-vitro, ANDA regulatory approval process, NDA approval process, BE and drug product assessment, in –vivo, Scale up process approval changes, Post marketing surveillance, Outsourcing BA and BE to CRO]]>
Master formula record, DMF (Drug Master File), Distribution records. Generic drugs product development Introduction , Hatch-Waxman act and Amendments, CFR (CODE OF FEDERAL REGULATION) ,Drug product performance, In-vitro, ANDA regulatory approval process, NDA approval process, BE and drug product assessment, in –vivo, Scale up process approval changes, Post marketing surveillance, Outsourcing BA and BE to CRO]]> Sat, 29 May 2021 15:51:43 GMT /slideshow/documentation-in-pharmaceutical-industry-248745573/248745573 simbupharma12@slideshare.net(simbupharma12) Documentation In Pharmaceutical Industry simbupharma12 Master formula record, DMF (Drug Master File), Distribution records. Generic drugs product development Introduction , Hatch-Waxman act and Amendments, CFR (CODE OF FEDERAL REGULATION) ,Drug product performance, In-vitro, ANDA regulatory approval process, NDA approval process, BE and drug product assessment, in –vivo, Scale up process approval changes, Post marketing surveillance, Outsourcing BA and BE to CRO <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ra031219-210529155143-thumbnail.jpg?width=120&height=120&fit=bounds" /> Master formula record, DMF (Drug Master File), Distribution records. Generic drugs product development Introduction , Hatch-Waxman act and Amendments, CFR (CODE OF FEDERAL REGULATION) ,Drug product performance, In-vitro, ANDA regulatory approval process, NDA approval process, BE and drug product assessment, in –vivo, Scale up process approval changes, Post marketing surveillance, Outsourcing BA and BE to CRO

Documentation In Pharmaceutical Industry from silambarasan I

]]> 2585 1 https://cdn.slidesharecdn.com/ss_thumbnails/ra031219-210529155143-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Pharmaceutical Validation /slideshow/pharmaceutical-validation-248745216/248745216 validation061119-210529153523
Introduction to Pharmaceutical Validation, Scope & Merits of Validation, Validation and calibration of Master plan, Hrs ICH & WHO guidelines for calibration and validation of equipment's, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ & P.Q. of facilities.]]>
Introduction to Pharmaceutical Validation, Scope & Merits of Validation, Validation and calibration of Master plan, Hrs ICH & WHO guidelines for calibration and validation of equipment's, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ & P.Q. of facilities.]]> Sat, 29 May 2021 15:35:22 GMT /slideshow/pharmaceutical-validation-248745216/248745216 simbupharma12@slideshare.net(simbupharma12) Pharmaceutical Validation simbupharma12 Introduction to Pharmaceutical Validation, Scope & Merits of Validation, Validation and calibration of Master plan, Hrs ICH & WHO guidelines for calibration and validation of equipment's, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ & P.Q. of facilities. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/validation061119-210529153523-thumbnail.jpg?width=120&height=120&fit=bounds" /> Introduction to Pharmaceutical Validation, Scope & Merits of Validation, Validation and calibration of Master plan, Hrs ICH & WHO guidelines for calibration and validation of equipment's, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ & P.Q. of facilities.

Pharmaceutical Validation from silambarasan I

]]> 2969 0 https://cdn.slidesharecdn.com/ss_thumbnails/validation061119-210529153523-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Transdermal Drug Delivery System /slideshow/transdermal-drug-delivery-system-248745136/248745136 transdermaldrugdeliverysystem221019-210529153110
Structure of skin and barriers, Penetration enhancers, Transdermal Drug Delivery Systems, Formulation and Evaluation]]>
Structure of skin and barriers, Penetration enhancers, Transdermal Drug Delivery Systems, Formulation and Evaluation]]> Sat, 29 May 2021 15:31:09 GMT /slideshow/transdermal-drug-delivery-system-248745136/248745136 simbupharma12@slideshare.net(simbupharma12) Transdermal Drug Delivery System simbupharma12 Structure of skin and barriers, Penetration enhancers, Transdermal Drug Delivery Systems, Formulation and Evaluation <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/transdermaldrugdeliverysystem221019-210529153110-thumbnail.jpg?width=120&height=120&fit=bounds" /> Structure of skin and barriers, Penetration enhancers, Transdermal Drug Delivery Systems, Formulation and Evaluation

Transdermal Drug Delivery System from silambarasan I

]]> 848 0 https://cdn.slidesharecdn.com/ss_thumbnails/transdermaldrugdeliverysystem221019-210529153110-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-simbupharma12-48x48.jpg?cb=1650427548 https://cdn.slidesharecdn.com/ss_thumbnails/invitrodrugproductperformance-converted-210529163318-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/invitro-drug-product-performance/248746216 Invitro drug product p... https://cdn.slidesharecdn.com/ss_thumbnails/herbalingredientsinoralcaresimbu280320-210529162848-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/herbal-ingredients-in-oral-care-248746158/248746158 Herbal ingredients in ... https://cdn.slidesharecdn.com/ss_thumbnails/perfumesimbu040420-210529162733-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/perfumes-248746146/248746146 Perfumes